Type 1 Diabetes occurs when the body’s immune system attacks insulin-producing pancreatic beta cells, causing the body to have insufficient insulin stores. Below are COVID news and research updates that specifically relate to Type 1 Diabetes.
Researchers have hypothesized how a Covid-19 infection may trigger the development of autoimmune diseases through three different mechanisms, which may intersect at different points of the inflammatory process. Various autoimmune diseases include rheumatoid arthritis, ankylosing spondylitis, Guillain-Barre syndrome, as well as Hashimoto’s and Graves disease.
Read More »A recent article published in the Virology Journal outlined what is currently known about COVID-19 infection and treatments in autoimmune disease patients, including specific diseases which pose a higher risk of infection, disease severity and hospitalization.
Read More »A recent study exploring the association between COVID-19 infection and the risk of developing autoimmune diseases was conducted by a team of researchers from various institutions in Taiwan using data from the “TriNetX database, which holds the largest global COVID-19 dataset.” The team analyzed the medical record data of 3.8 million patients in the U.S., of which 888,460 had received a COVID-19 diagnosis (polymerase chain reaction–confirmed) between January 1, 2020, and December 31, 2021.
Read More »Researchers evaluated the characteristics, severity, course of infection, and disease outcomes in COVID-19 patients with and without Systemic Autoimmune Rheumatic Diseases (SARDs). Patients with rheumatoid arthritis, systemic lupus erythematosus (SLE), Sjögren’s syndrome, Psoriasis, Type 1 Diabetes, Inflammatory Bowel Disease, and Glomerulonephritis, amongst others, were included in the study.
Read More »